Journal field guide · Indian firms only · Typical route: Category II AIF
Best Healthcare and Life Sciences PE funds in India
Indian PE funds focused on healthcare delivery, pharmaceuticals, diagnostics, medical devices and life sciences. This journal guide helps an allocator build an initial manager map before deeper fund and vehicle diligence.
Indian firms only
The manager must be headquartered in India. Foreign firms with an India office and regional or global platforms are excluded.
Best means mandate fit
This is an alphabetical research screen, not a return ranking. Fit depends on stage, sector, ticket, liquidity and portfolio role.
Public evidence first
Each included manager clears Rupeia's publication threshold for current evidence, named team, attributable positions and source depth.
Indian manager map
39 Indian Healthcare PE managers
Abakkus Four2Eight Opportunities Fund
Mid- to late-stage private equity; pre-IPO and special situations
Industrials, financial services, healthcare
Amara Partners Growth Fund I
Mid-market private equity and growth capital; significant-minority investments
Manufacturing, financial services, consumer, healthcare
Amicus Capital
Growth equity; mid-market
Financial services, consumer, healthcare, technology
Amicus Capital Partners India Fund II
Early-growth and growth equity
Financial services, consumer, healthcare, technology services
Ascent Capital (India)
India-focused growth equity; expansion capital and significant-minority investments
Technology, consumer, healthcare, financial services
BanyanTree India Growth Capital Fund
Growth equity; mid-market India
Consumer, financial services, healthcare, manufacturing
ChrysCapital
Growth + buyout (up to $200M/deal)
Fin services, health, pharma, consumer
ChrysCapital Fund X
Growth and control private equity
Healthcare, manufacturing, consumer, enterprise technology
Creaegis Investment Management
Growth equity; late-stage investments in digitally enabled Indian businesses
Consumer, financial services, healthcare, technology
CX Partners
Mid-market growth
Fin services, health, consumer
EAAA Discovery Fund I
Growth equity; mid-stage businesses
Consumer, financial services, healthcare, technology
Elevar Equity India Growth Platform
Early-growth private equity; impact and financial-inclusion growth capital
Financial inclusion, healthcare, education, agriculture
Epiq Capital II
Growth equity; late-stage technology and consumer platforms
Consumer technology, SaaS, fintech, healthcare technology
Faering Capital India Evolving Fund III
Growth equity
Consumer, financial services, healthcare, logistics
InvAscent India Life Sciences Fund IV
Healthcare and life-sciences growth equity
Pharma, healthcare delivery, medtech, animal health
Kedaara Capital
Control / co-control mid-market
Consumer, fin services, health, industrials
Kedaara Capital Fund IV
Growth and minority PE
Consumer, financial services, healthcare, software
Kotak Life Sciences Fund I
Early to growth-stage private equity across life sciences and healthcare
Pharmaceuticals, medical devices, diagnostics, digital health
Kotak Pre-IPO Opportunities Fund
Growth and late-stage private equity; pre-IPO
Consumer, technology, financial services, healthcare
Lighthouse Funds
Growth minority (consumer-heavy)
Consumer brands, health, specialty mfg
Lighthouse India Fund IV
Growth-stage private equity
Consumer, healthcare, specialty manufacturing, digital transformation
Lok Capital Growth Fund IV
Growth equity; technology-enabled businesses serving underserved markets
Financial services, climate, food & agriculture, healthcare
Motilal Oswal Alternates
Mid-market growth
Consumer, fin services, niche manufacturing, health
Motilal Oswal India Business Excellence Fund IV
Growth private equity; mid-market Indian businesses
Consumer, financial services, life sciences, manufacturing
Motilal Oswal India Business Excellence Fund V
Growth and late-stage minority private equity
Consumer, financial services, healthcare, niche manufacturing
Multiples Alternate Asset Management
Growth + selective control
Fin services, consumer, health, tech
Multiples Private Equity GIFT Fund IV
Growth equity and control-oriented mid-market private equity
Financial services, consumer, technology, healthcare
NIIF Strategic Opportunities Fund
Growth equity; active minority and control-oriented investments
New-age manufacturing, financial services, healthcare
Sabre Partners
Growth equity; mid-market
Financial services, fintech, healthcare, healthtech
Samara Capital
Buyout
Consumer, retail, health
Samara Capital Continuation Fund
Continuation vehicle; mid-market buyout and growth private equity
Healthcare, consumer, business services
Somerset Indus Fund III
Healthcare growth equity
Hospitals, diagnostics, pharmaceuticals
Stakeboat Capital
Growth (SME)
Health, consumer, tech services
Tata Capital Growth Fund
Growth minority
Manufacturing, services, health
True North
Control mid-market
Health, fin services, consumer
True North Fund V
Mid-market growth and buyout private equity
Healthcare, financial services, technology, consumer
True North Fund VI
Mid-market growth and buyout private equity
Financial services, healthcare, technology, industrials
True North Fund VII
Growth and minority PE
Healthcare, financial services, consumer, technology
ValueQuest S.C.A.L.E. Fund
Growth and late-stage private equity; significant-minority investments
Financial services, healthcare, technology, consumer
More Journal screens
Continue by sector or investment strategy.
Growth Equity
Read the India-only guide →
Buyout and Control
Read the India-only guide →
Mid-Market
Read the India-only guide →
Pre-IPO and Late Stage
Read the India-only guide →
Consumer
Read the India-only guide →
Financial Services
Read the India-only guide →
Manufacturing and Industrials
Read the India-only guide →
Real Assets and Infrastructure
Read the India-only guide →
Allocator workflow
Use the Journal to frame the search, then open the evidence.
Map
Identify Indian managers whose published mandate matches the sector or strategy.
Read
Open each linked research profile and separate established evidence from unresolved gaps.
Diligence
Compare the actual vehicle, team, attribution, terms and portfolio role before engagement.